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a  b  s  t  r  a  c  t
Extracellular  vesicles  (EVs)  have  been  recognized  as  a universal  method  of  cellular  communications
and  are reportedly  produced  in  bacteria,  archaea,  and  eukaryotes.  Bacterial  EVs  are  often  called  “Outer
Membrane  Vesicles”  (OMVs)  as  they  were  the  result  of  a controlled  blebbing  of  the  outer  membrane
of  gram-negative  bacteria  such as  Porphyromonas  gingivalis  (P. gingivalis).  Bacterial  EVs  are  natural
messengers,  implicated  in intra-  and  inter-species  cell-to-cell  communication  among  microorganism
populations  present  in  microbiota.  Bacteria  can incorporate  their  pathogens  into  OMVs;  the  content  of
OMVs  differs,  depending  on  the  type  of  bacteria.  The  production  of distinct  types  of OMVs  can  be  medi-
ated  by  different  factors  and  routes.  A recent  study  highlighted  OMVs  ability  to  carry  crucial  molecules
implicated  in  immune  modulation,  and,  nowadays,  they  are  considered  as  a way  to  communicate  andIn vivo imaging transfer  messages  from  the  bacteria  to the  host  and  vice  versa.  This  review  article  focuses  on  the  current
understanding  of OMVs  produced  from  major  oral bacteria,  P. gingivalis:  generation,  characteristics,  and
contents  as  well  as  the  involvement  in  signal  transduction  of host  cells  and  systemic  diseases.  Our  recent
study  regarding  the  action  of  P.  gingivalis  OMVs  in  the  living  body  is also  summarized.
©  2021  The  Authors.  Published  by  Elsevier  Ltd on behalf  of The  Japanese  Association  for  Dental













Signal transduction between cells, tissues, and organs is metic-
ulously regulated and is involved in cellular development, growth,
and diseases. These communications are initiated by direct or indi-
rect interactions. In the case of indirect interaction, “cytokines” or
“hormones,” released from immune cells and endocrine cells, are
involved respectively in cell survival, proliferation, differentiation,
and activity.
More recently, a novel intercellular indirect communication
system is gathering the attention of scientists. In this system,
cells enclose various substances (information) in small particles
and then release them to be transferred to other cells. The cargo
in which cells contain packaged substances is called extracellu-
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ar vesicles (EVs); they encompass cell-specific molecules such as
ucleic acids, proteins, sugars, and lipids. Over the last decade,
esearch in this area has exponentially expanded — its role has
ncovered various insights into the importance of areas such as
ancer and immunity. Under physiological or pathological condi-
ions, eukaryotic cells secrete various sizes of vesicles wrapped in
lasma or intracellular membrane. These extracellular vesicles are
isseminated in fluids – blood, saliva, urine, breast milk, amniotic
uid, etc. – and play an important role in various stages such as
evelopment, differentiation, immune response, and aging. Since
Vs are presumably released from all cells, they become critical
o every evolutionary process in both unicellular and multicellular
rganisms.
In contrast to the well-established various roles of EVs in
ukaryotic cell biology, outer membrane vesicles (OMVs), pro-
uced via blebbing of prokaryotic membranes, have frequently
een regarded as cell debris or microscopy artificial products.
ver the past decades, the role of OMVs produced gram-
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negative bacteria have been analyzed. OMVs nowadays have
been considered a very sophisticated mechanism for transport-
ing many molecular effectors, cell-cell interactions, nutrients,
interaction, host cell immune dysregulation, modulation, bacte-
rial aggregation, biofilm formation, etc. Some of OMVs-releasing
species reported include Porphyromonas gingivalis (P. gingivalis),
Actinobacillus actinomycetemcomitans, Borrelia burgdorferi,  and
Pseudomonas aeruginosa.  [1–4].
Periodontitis is among the most common human infection,
initiated by specific species of bacteria: Aggregatibacter actino-
mycetemcomitans, Tannerella forsythia, Treponema denticola, and
P. gingivalis [5]. The pathogenesis of periodontitis is mediated
through interactions between these microbial factors and the host
cells. In particular, P. gingivalis has been frequently associated
with specific types of periodontitis and possesses various mech-
anisms that favor the pathogenic process. P. gingivalis has been
observed within gingival tissues in vivo, suggesting that P. gingi-
valis may  invade deeper structures of the connective tissue [6].
On the other hand, P. gingivalis has been reported to be heavily
involved in a wide variety of systemic diseases including cardiology,
rheumatology, diabetology, oncology, immunology, and neurology
[7]. Several mechanisms have been reported to associate P. gingi-
valis with these systemic diseases. P. gingivalis affects endothelial
cells, platelets, leucocytes (mainly monocytes and macrophages),
cardiomyocytes, and smooth muscle cells to aggravate cardio-
vascular diseases such as atherosclerotic cardiovascular diseases
and myocardial infarction [8–10]. P. gingivalis enhances oxidative
stress, inflammatory and prothrombotic responses in endothelial
cells [11–13]. P. gingivalis fimbria and lipopolysaccharide (LPS)
increase the expression of adhesion molecules in endothelial cells,
such as vascular cell adhesion molecule-1, intercellular adhe-
sion molecule-1, and monocyte chemoattractant protein (P-seletin
and E-selectin) [14,15]. P. gingivalis fimbria and LPS also sup-
port monocyte to migrate and infiltrate into endothelial cells,
which differentiate monocyte into pro-inflammatory macrophages
[16,17]. More recently, P. gingivalis W83  strain was  reported to
invade into dermal microvascular cells via Intercellular Adhe-
sion Molecule 1 (ICAM-1) and inhibit the formation of vascular
networks [18]. Autoantibody against citrullinated proteins is con-
sidered an important pathological base of rheumatoid arthritis
(RA). Regarding rheumatology, circulating bacterial antibodies
and the anti-cyclic citrullinated peptide induced by periodontal
pathogens such as P. gingivalis seems to be involved in the pro-
gression of RA [19]. P. gingivalis is the only microorganism to
express the enzyme mediating protein citrullination called pep-
tidylarginine deiminases (PAD) [20]. P. gingivalis PAD is proposed
to break immunotolerance to citrullinated proteins, leading to the
occurrence of RA [20]. Among the reported P. gingivalis-elicited
mechanisms involved in diabetes, insulin resistance seems to be
the most significant. P. gingivalis infection stimulates inflammation
and elevates inflammatory markers, such as CRP and IL-6, leading
to insulin resistance [21]. More recently, it was reported that P. gin-
givalis causes insulin resistance by the phosphorylation of insulin
receptor through activation of mammalian target of rapamycin
and related genes in the mice fed with high-fat diet [22]. P. gin-
givalis LPS also is involved in obesity-associated insulin resistance
by inducing pro-inflammatory adipokine production and oxida-
tive stress in adipocytes [23]. P. gingivalis, reportedly, raises the
development of oral squamous cell carcinoma, esophageal and pan-
creatic cancers through epithelial-mesenchymal transition (EMT)
of oral epithelial cells, the prevention of epithelial cell apoptosis,
and the promotion of immune evasion, etc [8,24–26]. P. gingi-
valis modulates EMT  by regulating zinc-finger homeobox proteins
(ZEB1 and Zeb2) and GSK-3/-catenin/forkhead box-O1 (FOXO1)
[27]. Furthermore, P. gingivalis controls epithelial apoptosis many
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athways as well as mitochondrial apoptosis-related factors (Bad,
cl-2, and Bax) [8,26,28]. In the field of neurology, P. gingivalis infec-
ion has been suggested to be the risk of Alzheimaer’s disease (AD)
nd depression by several epidemiological studies [29,30]. Ani-
al  experiments also support the possible relevance of P. gingivalis
n AD pathogenesis characterized as microglia-mediated neuroin-
ammation and -amyloid (A)  accumulation in neurons, which
mpaires cognitive function and reduces in learning and memory
8,31,32]. P. gingivalis and its LPS are thought to be involved in the
rogression of AD via cathepsin B (CatB), a crucial mediator for A
eposition and neuroinflammation [31,33]. Inflammatory media-
ors - TNF-, IL-1, IL-6, and IL-8 - released from host cells infected
ith P. gingivalis are also reported to associate with the progression
f AD by reaching central nervous system via hematoencephalic
arieer-free area [34,35].
Interestingly, in addition to these mechanisms described above,
everal reports demonstrated the involvement of P. gingivalis OMVs
n the etiology of systemic diseases including diabetes and vas-
ular calcification. P. gingivalis OMVs translocates to the liver
nd attenuates insulin sensitivity and hepatic glycogen synthe-
is by downregulating the Akt, -GSK3-FOXO1 pathway [36,37].
. gingivalis OMV  induces vascular smooth muscle cell calcifica-
ion through activation of ERK1/2-Runx2 [38]. These observations
ead us to the advanced interpretation that P. gingivalis-involved
iseases, including periodontitis, are not only caused by direct
ocal infection and transfer of virulence factors into host cells, but
lso by strategic indirect communication devices of P. gingivalis.
mong the several factors associated with P. gingivalis-involved
iseases, increasing evidence suggests that OMVs contribute to the
athogenesis of this bacterium. Therefore, the function of OMVs
ynthesized from P. gingivalis will be reviewed and discussed here.
. P. gingivalis OMVs generation
Based on their membrane properties, bacteria are classified
s Gram-negative or Gram-positive. Gram-negative bacteria are
haracterized by a double plasma membrane layer separated by
he periplasm. Most EVs produced by Gram-negative are thought
o be OMVs, which are composed of a single bilayer membrane
erived from an outer membrane and contain periplasmic con-
ents such as lipids, outer membrane proteins, lipoproteins, and
ipids [39,40]. P. gingivalis, a gram-negative bacterium, has been
bserved to produce vesicles on its cell surface and release them to
ts environments [41,42].
The mechanism of OMVs biogenesis has not been fully eluci-
ated, despite their biological importance. The curvature of the
MVs membrane is approximately 14 times that of the extracel-
ular membrane, suggesting that OMVs generation requires energy
xpense due to the prominent curvature of the outer membrane
40]. These observations indicate that P. gingivalis OMVs generation
f could be completed by increasing the production of specific inner
r outer leaflet lipids. This is carried out by anionic lipopolysaccha-
ide (A-LPS) on the outer surface and its related C-terminal domain
CTD) family proteins [40].
Various factors have been reported to be involved in the for-
ation of OMVs. Autolysins, endogenous murein hydrolases that
leave covalent bonds in the peptidoglycan of the cell wall, play
n important role, physiologically, in bacterial growth, cell divi-
ion, cell wall remodeling, peptidoglycan turnover, and recycling
43]. Autolysin is involved in the release of P. gingivalis OMVs [44].
here are three types of gingipains in P. gingivalis: lysine-specific
ingipain (Kgp), arginine-specific gingipain A (RgpA), and arginine-
pecific gingipain B (RgpB) [45,46]. These gingipains are encoded by
he rgpA, rgpB, and kgp, genes respectively. In contrast to the mature
gpB, which only possesses a catalytic domain, RgpA and Kgp have
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Fig. 1. Schematic summary of the P. gingivalis OMVs generation.
OMVs are composed of a single bilayer membrane derived from an outer membrane and contain periplasmic contents such as lipids, outer membrane proteins, lipoproteins,































proteins. Dephosphorylation of lipid A of A-LPS by PG0027 induces the destabiliza
essential for the O-deacylation of LPS and for the coordinated secretion and attachm
homologous adhesin/hemagglutinin domains as a part of their C-
terminal extension [47]. Among them, the deletion of RgpA results
in a reduction of OMVs [48]. P. gingivalis LPS is the major com-
ponent of the outer membrane of the bacteria that stimulates the
innate immune system and is a key virulence factor which induce
the production of cytokines [49]. P. gingivalis has A-LPS, consisting
of phosphorylated branched mannan repeating unit attached to the
lipid A core [50]. A-LPS and PG0027, outer membrane proteins, are
also involved in the formation of OMVs [51]. PG0027 dephospho-
rylates lipid A of A-LPS; this process may  be necessary for optimal
OMVs formation. Dephosphorylation of lipid A of A-LPS, controlled
by PG0027, induces the destabilization of the outer membrane,
resulting in blebbing and the generation of OMVs [51].
The surrounding environment affects the generation of P. gingi-
valis OMVs. P. gingivalis can adapt to the surrounding environment,
and its gene expression is controlled by extracytoplasmic function
(ECF) sigma factors. SigP is one of these factors and mutation of
sigP increases the level of OMVs formed on the P. gingivalis cell sur-
face [52]. SigP is thought to be involved in activities – gingipain
activity, autoaggregation, hemagglutinination, vesicle formation,
antimicrobial susceptibility – associated with the bacterial surface
[52]. In addition, under hemin-limitation, the gravimetric yield of
OMVs increased by 2.5-folds, although cell yield did not changed.
Growth in hemin-excess conditions resulted in increased hemin-
binding capacities of OMVs [53].
3. P. gingivalis OMVs characteristics
There are several cases that P. gingivalis bacterial cells are not
detected in distant tissues or organs although P. gingivalis DNA
is present. Compared with P. gingivalis bacterial cells, P. gingivalis
OMVs have various functional advantages. For instance, P. gingivalis
OMVs possess some well-known bacterial virulence compared to





140f the outer membrane, resulting in blebbing and the generation of OMVs. LptO is
f A-LPS and CTD proteins. OM:  outer membrane; IM:  inner membrane.
–5 fold increase in gingipain levels in P. gingivalis OMVs compared
ith the levels in surface extracts of the original bacterial cells
54]. P. gingivalis OMVs, moreover, show the increased antigenicity,
hich may  result from the more concentrated immune-responsive
actors on the vesicles compared with the surface of bacterial cells
55,56]. Additionally, P. gingivalis OMVs bring bacterial DNA and
ignal molecules to distant target organs without degradation. In
he mice applied with P. gingivalis into gingival sulcus, DNA of P.
ingivalis was  detected in the liver by PCR. However, the bacterial
ells was not observed in the liver under strict examination by a
ransmission electron microscope [57]. It was  also reported that in
A patients P. gingivalis organisms are not observed in joint fluid
lthough its DNA was  detected [58]. P. gingivalis OMVs are thought
o be an important carrier of P. gingivalis DNA to distant organs
ithout the direct translocation of P. gingivalis bacteria cells.
Fig. 1 shows a schematic summary of the structure and rep-
esentative components of P. gingivalis OMVs. P. gingivalis OMVs
ere originally reported in the 1980s; however, the biological
athogenic functions were not immediately recognized. Similar to
hat of other gram-negative bacterial vesicles, the diameter of P.
ingivalis OMVs is approximately 50−250 nm but is most com-
only around 50 nm [59]. OMVs are not only just a part of a
acterial component, but also include a toxic complex of LPS and
roteolytic enzymes (proteases). Bacteria discharges vesicles like
issiles as a mechanism for survival and also to create an environ-
ent for growth and proliferation. LPS and the proteases associated
ith P. gingivalis OMVs are likely to represent the heat-stable and
he heat-unstable components, respectively [60].
The major outer membrane proteins Pgm6/7, which are homol-
gous to the OmpA protein in Escherichia coli, are important for
aintaining the integrity of the outer membrane. The loss of
gm6/7 induced wavy and irregular OM and increased the number
f vesicles and the rate of gingipain activity [61]. PGN 1251 (gtfB)
s also involved in the transition of gingipain to the cell surface.
H. Okamura et al. Japanese Dental Science Review 57 (2021) 138–146
Fig. 2. Involvement of P. gingivalis OMVs in aggregation of other microorganisms.




























P. gingivalis exerts its pathogen to different organs (some-
times to distant organs), manipulates the invasion of other cells,viscosus (A. v), S. cricetus (S. c), and S. mutans (S. m). Gingipains of P. gingivalis OMVs 
into  oral epitherial cells. (B), P. gingivalis OMVs supports viral entry into oral epithe
binding  to the antimicrobial chlorhexidine.
PGN 1251 (gtfB) shares homology with genes encoding for glyco-
syltransferase 1 with several bacteria. Both LPSs containing O side
chain polysaccharide (O-LPS) and anionic polysaccharide (A-LPS)
were not synthesized in gftB mutant bacteria, resulting in a com-
plete loss of surface-associated proteins including gingipain [62].
Furthermore, P. gingivalis possesses a unique CTD system essen-
tial for secretion and attachment to the cell surface. The attachment
of PgpB proteinases to the outer membrane is associated with
the presence of a conserved CTD of approximately 70-amino-acid
residues in the encoded sequences [63]. The outer membrane pro-
tein LptO is essential for the O-deacylation of LPS and for the
coordinated secretion and attachment of A-LPS and CTD proteins
[64]. It was also reported that OMVs are enriched in high molecular
weight A-LPS molecules. Sorting factors within P. gingivalis OMVs
is selective, and LPS plays an important role [65].
Lo A, et al. demonstrate that both FimR and FimS are involved
in P. gingivalis biofilm formation, including the regulation of genes
associated with fimbriation (Lo et al., 2010). Mantri et al. compared
the protein components of P. gingivalis OMVs using a fimbriated
strain (33277) and P. gingivalis of an afimbriated strain (W83) [54].
Gingipain and hemagglutinin were contained in the OMVs pro-
duced from both bacterial strains. FimC, FimD and FimE were found
in the OMVs of 33277 strain, but not in W83  vesicles, indicat-
ing that different species contain different factors in their own
OMVs.
P. gingivalis OMVs have been demonstrated to enter cells such as
human oral keratinocytes and gingival fibroblasts more effectively
than originating bacterial cells [55]. FimA, a well-known adhesion
responsible factor, is considered important for the adhesion and
invasion of P. gingivalis into the host cells. However, the OMVs
derived from the mutant strain of FimA were able to penetrate the
cells [54]. On the other hand, in the case of OMVs produced FimR-
deleted P. gingivalis, the penetration rate was significantly reduced.
Thus, FimR is most likely involved in the invasion of P. gingivalis
OMVs into host cells, not FimA.
d
i
141volved in autoaggregation of S. aureus (S. a). P. gingivalis OMVs  supports viral entry
lls. (C), P. gingivalis OMVs protect themselves and other species of oral bacteria by
. Supporting other microorganisms
Fig. 2 shows various functions of P. gingivalis OMVs. P. gingi-
alis OMVs may  protect other bacterial species from complement
ction; thus, favoring the pathogenic process of periodontitis. P.
ingivalis OMVs can aggregate a wide range of Streptococcus spp.,
usobacterium nucleatum, T. denticola, L. saburreum, Actinomyces
aeslundii, and Actinomyces viscosus [66,67]. Also, P. gingivalis OMVs
re capable of attaching to various molecules [68], which supports
he aggregation of S. cricetus and S. mutans as well as the attachment
f bacteria such as A. viscosus to the tooth surface [69]. Autoaggre-
ation of S. aureus in the presence of P. gingivalis OMVs is inhibited
y l-arginine, l-lysine, and l-cysteine, suggesting that gingipains
re involved in these effects.
It has been found that the receptor-independent invasion of
uman immunodeficiency virus-1 (HIV-1) into epithelial cells is
ediated by P. gingivalis. P. gingivalis OMVs promote mucosal
ransmission of HIV-1. Dynabeads technology showed that a spe-
ific interaction between HIV-1 and P. gingivalis OMVs supports
iral entry into oral epithelial cells [70]. Subsequently, HIV-1 was
everse-transcribed and viral DNA was  integrated into the genome
f these cells. OMVs released from P. gingivalis are thought to be
ehicles for HIV-1 and promote infection to the mucous mem-
ranes.
P. gingivalis OMVs bind to the antimicrobial chlorhexidine via
PS and protect themselves and other species of oral bacteria. In
uch a way, the interaction between bacteria in the oral cavity
ffects the sensitivity of microbes to drugs [71].
. Systemic diseasesisrupts phagocytosis, affects complement-related factors, and
nduces pro-inflammatory signaling cascades. Other review arti-































Fig. 3. Schematic summary of the effects of P. gingivalis OMVs on host cells.
P. gingivalis OMVs can effectively enter the host cells and destroy the tissues by dis
and  acquired immunity.
cles have already described the effects of P. gingivalis bacteria itself
on systemic diseases such as atherosclerosis and AD as well as its
involvement in signal transduction in disease-related cells [72].
Therefore, in this review, the role of P. gingivalis OMVs in these
systemic diseases is highlighted.
5.1. Arteriosclerosis
Atherosclerosis, a chronic inflammatory disease of the blood
vessels, is one of the most common causes of morbidity and
mortality worldwide. The association between atherosclerosis and
periodontitis has been epidemiologically suggested. In addition,
there is research to elucidate this by molecular biological strategy.
Bacteria and their products in dental plaque enter the bloodstream
from the infected site, and become involved in arteriosclerosis and
thromboembolic events [73–76]. Platelet aggregation is considered
important for atherosclerotic plaque formation. P. gingivalis OMVs
possess powerful platelet aggregation activity [77], implying that
P. gingivalis is most causative agent for arterial infarction.
Foam cells, fat-storage macrophages indicating signs of plaque
formation or atherosclerosis, are generally associated with an
increased risk of heart attack and stroke. It was also demonstrated
that P. gingivalis OMVs stimulates foam cell formation in murine
macrophage cells [78]. In addition, several studies reported that
P. gingivalis OMVs induced LDL aggregation, which then induced
murine macrophage to form foam cells [79,80]. Thus, P. gingi-
valis OMVs released from periodontitis into the circulation may
deliver virulence factors to the arterial wall to initiate or promote
foam cell formation in macrophages and contribute to atheroma
development. P. gingivalis OMVs are more potent inducers of
the inflammatory response associated with the development of
atherosclerosis [81].5.2. Alzheimer’s disease
Research concerning AD is also being conducted with the focus





142g the immune system and regulating cellular responses involved in inflammation
ations of prospective and retrospective population-based data,
he presence of chronic inflammation for over 10 years increases
he risk of developing sporadic AD by more than two times [82].
n in vivo experiments, P. gingivalis infection induces pathological
henomena such as inclusive of extracellular amyloid plaques and
nhances phosphorylation of tau, characteristics of AD-like pheno-
ype. Other studies have also investigated the decline in cognitive
unctions in AD patients with untreated periodontitis [82]. It seems
hat P. gingivalis OMVs are being used effectively as a trigger for
nflammation and inflammatory mediators as a result of OMVs
ttack, which may  lead to organic and functional changes that
efine inflammation and impaired cognitive abilities typical of AD.
.3. Rheumatoid arthritis
P. gingivalis has been recently hailed as a potential etiology
f autoimmune disease RA. In particular, PAD of P. gingivalis is
nvolved in the citrullination of bacterial or host cell proteins. PAD
hen induces the production of anticitrullinated protein antibod-
es, leading to the loss of tolerance to citrullinated proteins in
A patients. PAD exists in the form of two  variants: the outer-
embrane-bound state and the soluble secreted state [83,84]. This
ifferent feature of PAD is closely related to the transport system
or PAD excretion, and PAD binds to the outer membrane via A-LPS
nchoring [85]. As a result, in many cases, PAD is present in OMVs
ecretion (less common in the soluble state). Interestingly, some P.
ingivalis strains showed a reduced PAD binding to OMVs, which
as closely related to the substitution of 373 Glutamine for lysine
esidues [86]. It is strongly suggested that the glutamine residue
n this part is involved in the association between PAD and OMVs.
ecently, a comparative analysis of wild type P. gingivalis and PAD
eficient strains was performed [87]. In this report, 51 citrullinated
roteins (51 of 78) of wild type OMVs were identified, of which
ost were assumed to have been translocated to the bacterial sur-
ace. PAD transferred to P. gingivalis OMVs seems to be strongly
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6. The effects of OMVs on host cells
6.1. Immune cells
Fig. 3 shows a schematic summary of the effects of P. gingi-
valis OMVs on host cells. P. gingivalis OMVs can be used offensively
as delivery systems for virulence factors and defensively to aid in
the survival of the bacterium in hostile environments. P. gingivalis
OMVs can enter cells more effectively than originating bacterial
cells [55]. P. gingivalis OMVs seem to contribute to tissue destruc-
tion by disrupting the immune system and regulating cellular
responses involved in inflammation and acquired immunity.
OMVs play a role in local immune evasion strategies that pro-
mote monocyte unresponsiveness and make microbial detection
difficult [72]. P. gingivalis OMVs have been reported to contribute
to the loss of LPS receptor, a membrane-bound CD14 receptor. Such
a phenomenon results in a hyporesponsiveness of macrophages
to LPS stimulation, which may  contribute to an increased vir-
ulence capacity of P. gingivalis. Furthermore, some strains of P.
gingivalis can raise matrix metalloproteinase 9 (MMP9) activity
in macrophages and may  be involved in plaque disruption. In
the destructive periodontitis, P. gingivalis stimulates monocytes
primed with IFN to release IL-12, thereby enhancing IFN accu-
mulation in T-cell populations [88]. Gingipain on the surface of
P. gingivalis OMVs membrane induces IL-8 cleavage and activa-
tion, leading to the recruitment of neutrophils [89]. P. gingivalis
OMVs induce nitric oxide (NO) production in RAW264.7 cells [90].
Nakao et al. investigated the effect of P. gingivalis OMVs on host
immune response and tissue destruction during P. gingivalis infec-
tion. P. gingivalis OMVs had high antigenic, and absorption of
patient sera with OMVs greatly reduced reactivity with whole cells
of P. gingivalis [91]. Interestingly, P. gingivalis OMVs suppress mono-
cyte unresponsiveness to living P. gingivalis but maintain bacterial
responsiveness to DNA. TLR2 plays a central role in the innate
immunity of P. gingivalis, but TLR4 appears to have a selective role
in the response to P. gingivalis OMVs [92].
Some reports reveal the immense ability of P. gingivalis OMVs
to induce inflammation compared with that of P. gingivalis bac-
teria itself. Treatment of P. gingivalis OMVs immensely stimulates
the production of TNFa, IL-12p70, IL-6, IL-10, IFNb, and NO in
macrophages, whereas direct infection of P. gingivalis shows a sig-
nificantly lower effect [93]. P. gingivalis OMVs stimulation causes
a metabolic shift in macrophage and increases the expression of
genes important for glycolysis and decreases the expression of
genes related to the TCA cycle. P. gingivalis OMVs, without the
direct infection of P. gingivalis, induces inflammasome activation
(activation of Caspase-1 and production of IL-ib and IL-18). These
findings indicate that P. gingivalis and P. gingivalis OMVs have differ-
ent effects on macrophage inflammatory phenotype, mitochondria
function, inflammasome activation, etc.
Cecil et al. investigated immuno-modulatory effects of P. gingi-
valis OMVs on monocytes and differentiated macrophages [94]. P.
gingivalis OMVs were phagocytosed into monocytes and M (naïve)
and M (IFNg) macrophages. P. gingivalis OMVs induced NF-kB acti-
vation and cytokine secretion such as TNFa, IL-8, and IL-1b. P.
gingivalis OMVs also induced anti-inflammatory IL-10 secretion
[94,95]. These observations indicate that P. gingivalis OMVs inter-
fere with the reaction of host immune cells and may  contribute to
local immune evasion.
6.2. Non-immune cellsP. gingivalis OMVs affect non-immune cell function and elicit
signal transduction. P. gingivalis OMVs significantly inhibit the pro-
liferation of human gingival fibroblasts capillary tube formation in
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ingivalis OMVs enter gingival epithelial cells via lipid rafts through
he actin filament assembly in phosphatidylinositol 3-kinase
nd Rac1 dependently. After entry, OMVs-associated gingipains
egrade cellular proteins, which are essential for intracellular
ransferrin and cellular migration, leading to their functional
mpairment [97]. P. gingivalis OMVs induce the expression and
ctivity of eNOS in HUVEC through Rho kinase (ROCK)-stimulated
RK1 / 2 and p38 MAPK [98]. P. gingivalis OMVs promote calcifica-
ion of vascular smooth muscle cells, implying the involvement in
rteriosclerosis. P. gingivalis OMVs enhance the expression of mark-
rs of osteoblast differentiation and calcification in vascular smooth
uscle cells and calcification via ERK1 / 2-Runx2 [38]. In addition,
. gingivalis OMVs induce oral squamous epithelial cell detachment,
hich is inhibited by preincubating P. gingivalis OMVs with anti-
ingipain serum. E-selectin and ICAM-1 are important factors for
he adhesion of leukocytes to endothelial cells. P. gingivalis OMVs
nduced the expression of E-selectin and ICAM-1 on the surfaces of
ascular endothelial cells. These findings demonstrate that P. gin-
ivalis OMVs are capable of inducing acute inflammation, which is
haracterized by the accumulation of large numbers of neutrophils
n connective tissues [99].
. Vaccination
Periodontitis is the most prevalent infectious disease and is
elated to oral and systemic health; therefore, novel prophylaxis to
revent the disease is highly desirable. There are several attempts
o develop novel vaccines using P. gingivalis OMVs and some
esirable results have been obtained. Nasally or percutaneously
dministered 40-kDa outer membrane protein of P. gingivalis elicits
pecific antibodies, which inhibits the co-aggregation activity of P.
ingivalis, implying that this fragmented outer membrane protein
s useful for vaccination against chronic periodontitis [100–102].
 few years later, Nakao et al. assessed the capacity of P. gingi-
alis OMVs as a vaccine antigen by intranasal immunization to
ALB/c mice. They proposed that P. gingivalis OMVs are an intrigu-
ng immunogen for the development of a periodontitis vaccine [56].
ecently, their group performed sub-immunoproteome analysis
sing P. gingivalis OMV-immunized mouse serum samples to iden-
ify immunodominant antigens. As a result, it has been reported
hat LPS and A-LPS-modified proteins in P. gingivalis OMVs are
mmunodominant determinants that lead to the production of P.
ingivalis-specific antibodies in mice [103].
P. gingivalis OMVs are stable structurally and functionally, resis-
ant to proteinase K, able to withstand long-term storage, and
dvantageous in delivering components to host immune cells. The
hallenge to generate antibodies specific to P. gingivalis is pro-
eeded by using intranasal vaccination of P. gingivalis OMVs [104].
. Contents of P. gingivalis OMVs and movement in the  host
ody
Recent studies using genetic, proteomic, and morphological
ools have demonstrated that P. gingivalis OMVs include a variety
f virulence factors provided by parental cells [70]. As described
bove, P. gingivalis OMVs possess various components of outer
embrane constituents, including LPS, muramic acid, a capsule,
mbriae, and gingipains [41,42]. P. gingivalis OMVs are potent vehi-
les for transmitting virulence factors into the host cells and are
nvolved in the etiology of periodontitis.
The proteins in P. gingivalis OMVs were examined by LC–MS/MS
nalysis [105]. Most proteins are derived from outer membrane or
eriplasm, which are distributed on the vesicle surface, membrane,
umen, etc. Numerous virulence factors including all CTD proteins
re shown to be preferentially packaged into P. gingivalis OMVs.






Fig. 4. Experimental strategy for tracking the movement of P. gingivalis OMVs in viv
We  established a novel tracking system of P. gingivalis OMVs by in vivo imaging. P.
OMVs were injected intraperitoneally to mice. Cy7 fluorescence was  detected in the
Small RNAs are also incorporated in P. gingivalis OMVs. P. gin-
givalis has also been shown to have small RNAs similar in size to
eukaryote microRNAs (miRNAs). Small RNA, similar in size to miR-
NAs (miRNA-size, small RNAs or msRNA), has a length of 15–25
nucleotides, and its precursor is assumed to be the secondary
structure of a hairpin loop. Deep sequencing reveals that msRNA
expressed on P. gingivalis are secreted via OMVs [106]. P. gingi-
valis OMVs are also found to be capable of transporting RNAs to
eukaryotic cells. These exogenous msRNA are reported to suppress
cytokines in Jurkat cells [106]. msRNA may  be a new bacterial sig-
naling molecule that connects bacteria to humans.
As far as we know, no reports have directly analyzed the exis-
tence and pathogenetic properties of P. gingivalis OMVs in human
clinical isolates. Gabarrini et al. primitively tested P. gingivalis’s
peptidylarginine deiminase using unfiltered growth medium frac-
tions of 93 clinical isolates, which contain both OMV-associated
proteins [86]. In recent years, we showed that P. gingivalis OMVs
were equipped with P. gingivalis-derived proteases gingipains and
translocated to the liver in mice (Fig. 4). In these mice, the hep-
atic glycogen synthesis decreased in response to insulin, and thus,
high blood glucose levels were maintained. P. gingivalis OMVs also
attenuated the insulin-induced Akt/glycogen synthase kinase-3 
(GSK-3) signaling in a gingipain-dependent fashion in hepatic
HepG2 cells [57].
9. Future direction
Small particles secreted from oral bacteria, which was initially
thought to be debris or artificial products, are now considered the
most sophisticated tools conducted by oral bacteria. Oral bacteria
can use these tools to deliver their nucleic acids and proteins to
local and distant organs and tissues. In recent years, our prelimi-
nary study has shown that P. gingivalis invades macrophages and
hides pathogenic factors in EVs released by the macrophages. The
released EVs in turn can reach distant organs such as the brain and
the lungs more efficiently. What tools should we utilize to cope with
such a tricky oral bacterial strategy? The communication between
oral bacteria and the host cells via small vesicles is still unknown
to a large extent, and further clarification is strongly required.
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